(Q33342189)

25 July 2017

Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation (English)

1 reference

25 July 2017

Tokimasa S

1

1 reference

25 July 2017

Hara J

2

1 reference

25 July 2017

Osugi Y

3

1 reference

25 July 2017

Ohta H

4

1 reference

25 July 2017

Matsuda Y

5

1 reference

25 July 2017

Fujisaki H

6

1 reference

25 July 2017

Sawada A

7

1 reference

25 July 2017

Kim JY

8

1 reference

25 July 2017

Sashihara J

9

1 reference

25 July 2017

Amou K

10

1 reference

25 July 2017

Miyagawa H

11

1 reference

25 July 2017

Tanaka-Taya K

12

1 reference

25 July 2017

Yamanishi K

13

1 reference

25 July 2017

Okada S

14

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Bone Marrow Transplantation

25 July 2017

1 reference

25 July 2017

29

1 reference

25 July 2017

7

1 reference

25 July 2017

595-598

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703423

25 July 2017

0 references

cites work

Human herpesviruses 6 and 7: identification of newly recognized viral pathogens and their association with human disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

Reactivation of human herpesvirus 6 by infection of human herpesvirus 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

Human herpesvirus-6 in transplantation: an emerging pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

Human herpesvirus 6 DNA in skin biopsy tissue from marrow graft recipients with severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

7 January 2021

Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

7 January 2021

Human herpesvirus 6 infection and associated pathogenesis following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

7 January 2021

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

7 January 2021

Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

7 January 2021

Susceptibility of human herpesvirus 6 to antivirals in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

7 January 2021

Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

7 January 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703423

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703423

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference